CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Panacos, Vitex Merging In $27M Stock Exchange, Plus Milestones (BioWorld Today)
News | 06. 04. 2004
Panacos Pharmaceuticals
Bringing together two infectious disease pipelines, Panacos Pharmaceuticals Inc. entered a definitive merger agreement with V.I. Technologies Inc., also called Vitex.
